Gilotrif (Afatinib) in Advanced Non-Small Cell Lung Cancer Patients Pre-treated With Erlotinib or Gefitinib
Status:
Completed
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
The program will provide early access to the investigational drug gilotrif in patients with
advanced non-small cell lung cancer who have failed at least 6 months on erlotinib or
gefitinib.
The Compassionate Use Programme will also provide additional safety information on gilotrif
use.